Convallari-valeriana drops (Drops) Instructions for Use
ATC Code
C01EX (Other combined drugs for the treatment of heart diseases)
Active Substances
Valerian (BP British Pharmacopoeia)
Herba Convallariae (SP USP United States Pharmacopoeia)
Clinical-Pharmacological Group
Herbal preparation with cardiotonic and sedative effects
Pharmacotherapeutic Group
Herbal sedative
Pharmacological Action
A combined herbal preparation that has cardiotonic, sedative, and spasmolytic effects.
Indications
- Use as part of complex therapy for conditions of increased nervous excitability and restlessness.
- Employ for managing nonorganic insomnia and other sleep disorders.
- Utilize for the relief of spasms of the gastrointestinal tract, including abdominal colic.
- Administer as an auxiliary agent in chronic heart failure of functional class I-II.
ICD codes
| ICD-10 code | Indication |
| F45.3 | Somatoform dysfunction of the autonomic nervous system |
| F48.0 | Neurasthenia |
| F51.0 | Nonorganic insomnia |
| I50.0 | Congestive heart failure |
| R10.4 | Other and unspecified abdominal pain (colic) |
| R45.1 | Restlessness and agitation |
| ICD-11 code | Indication |
| 6A8Z | Affective disorders, unspecified |
| 6C20.Z | Bodily distress disorder, unspecified |
| 7A00 | Chronic insomnia |
| 7A01 | Acute insomnia |
| 7A0Z | Insomnia disorders, unspecified |
| BD10 | Congestive heart failure |
| DD93.1 | Infantile colic |
| MB24.F | Restlessness |
| MD81.4 | Other and unspecified abdominal pain |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally. For adults, use 20 drops taken two to three times per day.
For children over 12 years of age, adjust the dose to 1 to 12 drops, with the exact number determined by the physician based on the child’s age and clinical condition.
Adverse Reactions
Monitor for systemic reactions such as muscle weakness and headache.
Be aware of potential allergic reactions. Note that prolonged use may lead to constipation.
Contraindications
- Do not use in patients with endocarditis, myocarditis, or known hypersensitivity to any component of the combination.
- This drug is contraindicated during pregnancy and throughout the lactation period (breastfeeding).
- Administration is prohibited for children under 12 years of age.
Use in Pregnancy and Lactation
Contraindicated during pregnancy and lactation (breastfeeding).
Use in Hepatic Impairment
With caution:liver diseases.
Pediatric Use
The drug is contraindicated for use in children and adolescents under 18 years of age.
Special Precautions
Influence on the ability to drive vehicles and mechanisms
During treatment, caution must be exercised when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Drug Interactions
This preparation enhances the sedative effect of hypnotics and other agents that depress the central nervous system.
Concomitant use with alcohol, tranquilizers, and neuroleptics may lead to excessive CNS depression; exercise caution and consider dose adjustments.
Overdose
Symptoms of overdose may include pronounced sedation, drowsiness, dizziness, and bradycardia.
In case of suspected overdose, discontinue the medication immediately and initiate symptomatic and supportive treatment. Gastric lavage and administration of activated charcoal may be considered.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Oral drops: 25 ml dropper bottle.
Marketing Authorization Holder
Kirov Pharmaceutical Factory, SUE (Russia)
Dosage Form
| Convallari-valeriana drops | Oral drops: 25 ml dropper bottle. |
Dosage Form, Packaging, and Composition
| Oral drops | 100 ml |
| Lily of the valley tincture | 50 ml |
| Valerian tincture | 50 ml |
25 ml – dropper bottles (1) – cardboard packs.
Oral drops: bottle 25 ml
Marketing Authorization Holder
Kirov Pharmaceutical Factory, SUE (Russia)
Dosage Form
| Convallari-valeriana drops | Oral drops: bottle 25 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 100 ml |
| Lily of the valley tincture | 50 ml |
| Valerian tincture | 50 ml |
25 ml – dark glass bottles (1) – cardboard packs.
Oral drops: bottle 25 ml
Marketing Authorization Holder
Yaroslavl Pharmaceutical Factory, CJSC (Russia)
Dosage Form
| Convallari-valeriana drops | Oral drops: bottle 25 ml |
Dosage Form, Packaging, and Composition
| Oral drops | 100 ml |
| Lily of the valley tincture | 50 ml |
| Valerian tincture | 50 ml |
25 ml – dark glass bottles (1) – cardboard packs.
